Myriad Genetics, Inc. (NASDAQ:MYGN) Q3 2023 Earnings Call Transcript

Matt Scalo: Good afternoon and welcome to Myriad Genetics Third Quarter 2023 Earnings Call. During the call, we will review the financial results we released today.

Related Keywords

California ,United States ,South San Francisco ,Salt Lake ,Rachel Vatnsdal ,Nicole Lambert ,Mark Verratti ,Bryan Riggsbee ,Bryan Rigsby ,Evie Koslosky ,Sam Raha ,Raymond James ,Matt Scalo ,Matt Sykes ,Andrew Cooper ,Elizabeth Koslosky ,Paul Diaz ,Exchange Commission ,Lab Of The ,Women Health ,Walgreens ,Women Health On Slide ,Goldman Sachs ,Genetics Women Health ,Onsite Women Health ,Nasdaq ,Genetics Inc ,Myriad Genetics ,Call Transcript November ,Myriad Genetics Third Quarter ,Senior Vice President ,Chief Executive Officer ,Chief Financial Officer ,Chief Commercial ,Best Places ,Net Promoter Scores ,Foresight Universal Plus ,Chief Operating Officer ,Chief Commercial Officer ,Genetics Women ,Optum Genomics ,Investor Day ,Onsite Women ,Investor Relations ,Risk High Reward Businesses ,Small Cap Biotech Stocks ,Massive Potential According ,Myriad Genetics Inc ,